Overview
Availability
- Professor Steve Deitelzweig is:
- Available for supervision
Works
Search Professor Steve Deitelzweig’s works on UQ eSpace
2020
Journal Article
Effectiveness and Safety of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus
Lip, Gregory Y.H., Keshishian, Allison V., Kang, Amiee L., Li, Xiaoyan, Dhamane, Amol D., Luo, Xuemei, Balachander, Neeraja, Rosenblatt, Lisa, Mardekian, Jack, Nadkarni, Anagha, Pan, Xianying, Di Fusco, Manuela, Garcia Reeves, Alessandra B., Yuce, Huseyin and Deitelzweig, Steven B. (2020). Effectiveness and Safety of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus. Mayo Clinic Proceedings, 95 (5), 929-943. doi: 10.1016/j.mayocp.2019.05.032
2020
Journal Article
Major bleed costs of atrial fibrillation patients treated with factor Xa inhibitor anticoagulants
Fermann, Gregory J., Lovelace, Belinda, Christoph, Mary J., Lingohr-Smith, Melissa, Lin, Jay and Deitelzweig, Steven B. (2020). Major bleed costs of atrial fibrillation patients treated with factor Xa inhibitor anticoagulants. Journal of Medical Economics, 23 (12), 1409-1417. doi: 10.1080/13696998.2020.1837502
2020
Journal Article
Comparison of readmissions among hospitalized nonvalvular atrial fibrillation patients treated with oral anticoagulants in the United States
Deitelzweig, Steven, Baker, Christine L., Dhamane, Amol D., Mardekian, Jack, Dina, Oluwaseyi, Rosenblatt, Lisa, Russ, Cristina, Poretta, Tayla, Lingohr-Smith, Melissa and Lin, Jay (2020). Comparison of readmissions among hospitalized nonvalvular atrial fibrillation patients treated with oral anticoagulants in the United States. Journal of Drug Assessment, 9 (1), 87-96. doi: 10.1080/21556660.2020.1750418
2020
Journal Article
Utilization of anticoagulants and predictors of treatment among hospitalized patients with atrial fibrillation in the USA
Deitelzweig, Steven, Dhamane, Amol D., Di Fusco, Manuela, Russ, Cristina, Rosenblatt, Lisa, Lingohr-Smith, Melissa and Lin, Jay (2020). Utilization of anticoagulants and predictors of treatment among hospitalized patients with atrial fibrillation in the USA. Journal of Medical Economics, 23 (12), 1-12. doi: 10.1080/13696998.2020.1832099
2020
Journal Article
Comparison of inpatient admission rates of patients treated with apixaban vs. warfarin for venous thromboembolism in the emergency department
Deitelzweig, Steven, Hlavacek, Patrick, Mardekian, Jack, Rosenblatt, Lisa, Russ, Cristina, Tuell, Kenneth, Lingohr-Smith, Melissa, Lin, Jay and Guo, Jennifer D. (2020). Comparison of inpatient admission rates of patients treated with apixaban vs. warfarin for venous thromboembolism in the emergency department. Hospital Practice, 48 (1), 41-48. doi: 10.1080/21548331.2020.1718925
2019
Journal Article
Budget impact analysis of betrixaban for venous thromboembolism prophylaxis in nonsurgical patients with acute medical illness in the United Kingdom
Guy, Holly, Laskier, Vicki, Fisher, Mark, Bucior, Iwona, Deitelzweig, Steven and Cohen, Alexander T. (2019). Budget impact analysis of betrixaban for venous thromboembolism prophylaxis in nonsurgical patients with acute medical illness in the United Kingdom. Expert Review of Pharmacoeconomics and Outcomes Research, 20 (3), 1-9. doi: 10.1080/14737167.2019.1629905
2019
Journal Article
Cost-effectiveness of betrixaban compared with enoxaparin for venous thromboembolism prophylaxis in nonsurgical patients with acute medical illness in the United States
Guy, Holly, Laskier, Vicki, Fisher, Mark, Neuman, W. Richey, Bucior, Iwona, Deitelzweig, Steven and Cohen, Alexander T. (2019). Cost-effectiveness of betrixaban compared with enoxaparin for venous thromboembolism prophylaxis in nonsurgical patients with acute medical illness in the United States. Pharmacoeconomics, 37 (5), 701-714. doi: 10.1007/s40273-018-0757-8
2019
Journal Article
Frequency of hospital readmissions for venous thromboembolism and associated hospital costs and length of stay among acute medically ill patients in the US
Amin, Alpesh, Deitelzweig, Steven, Bucior, Iwona, Lin, Jay, Lingohr-Smith, Melissa, Menges, Brandy and Neuman, W. Richey (2019). Frequency of hospital readmissions for venous thromboembolism and associated hospital costs and length of stay among acute medically ill patients in the US. Journal of Medical Economics, 22 (11), 1-7. doi: 10.1080/13696998.2019.1618862
2019
Journal Article
Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients
Deitelzweig, Steven, Keshishian, Allison, Li, Xiaoyan, Kang, Amiee, Dhamane, Amol D., Luo, Xuemei, Balachander, Neeraja, Rosenblatt, Lisa, Mardekian, Jack, Pan, Xianying, Nadkarni, Anagha, Di Fusco, Manuela, Garcia Reeves, Alessandra B., Yuce, Huseyin and Lip, Gregory Y. H. (2019). Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients. Journal of the American Geriatrics Society, 67 (8) jgs.15956, 1662-1671. doi: 10.1111/jgs.15956
2019
Journal Article
Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with -vitamin K antagonists in patients with non-valvular atrial fibrillation: a systematic literature review
Deitelzweig, Steve and Lip, Gregory Y. H. (2019). Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with -vitamin K antagonists in patients with non-valvular atrial fibrillation: a systematic literature review. Expert Review of Pharmacoeconomics and Outcomes Research, 19 (3), 1-2. doi: 10.1080/14737167.2019.1592834
2018
Journal Article
Hospital Resource Utilization and Costs Associated With Warfarin Versus Apixaban Treatment Among Patients Hospitalized for Venous Thromboembolism in the United States
Deitelzweig, Steven, Guo, Jennifer D., Hlavacek, Patrick, Lin, Jay, Wygant, Gail, Rosenblatt, Lisa, Gupta, Anu, Pan, Xianying, Mardekian, Jack, Lingohr-Smith, Melissa, Menges, Brandy, Marshall, Alexander and Nadkarni, Anagha (2018). Hospital Resource Utilization and Costs Associated With Warfarin Versus Apixaban Treatment Among Patients Hospitalized for Venous Thromboembolism in the United States. Clinical and Applied Thrombosis-Hemostasis, 24 (9_suppl), 261S-268S. doi: 10.1177/1076029618800806
2018
Journal Article
Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients The ARISTOPHANES Study
Lip, Gregory Y. H., Keshishian, Allison, Li, Xiaoyan, Hamilton, Melissa, Masseria, Cristina, Gupta, Kiran, Luo, Xuemei, Mardekian, Jack, Friend, Keith, Nadkarni, Anagha, Pan, Xianying, Baser, Onur and Deitelzweig, Steven (2018). Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients The ARISTOPHANES Study. Stroke, 49 (12), 2933-2944. doi: 10.1161/STROKEAHA.118.020232
2018
Journal Article
Impact of warfarin persistence on health-care utilization and costs among patients with atrial fibrillation managed in anticoagulation clinics in the United States
Deitelzweig, Steven B., Evans, Michael, Trocio, Jeffrey, Gupta, Kiran, Lingohr-Smith, Melissa, Menges, Brandy and Lin, Jay (2018). Impact of warfarin persistence on health-care utilization and costs among patients with atrial fibrillation managed in anticoagulation clinics in the United States. Clinical and Applied Thrombosis-Hemostasis, 24 (2), 364-371. doi: 10.1177/1076029616685427
2018
Journal Article
All-Cause, Stroke/Systemic Embolism-, and Major Bleeding-Related Health-Care Costs Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Oral Anticoagulants
Deitelzweig, Steve, Luo, Xuemei, Gupta, Kiran, Trocio, Jeffrey, Mardekian, Jack, Curtice, Tammy, Hlavacek, Patrick, Lingohr-Smith, Melissa, Menges, Brandy and Lin, Jay (2018). All-Cause, Stroke/Systemic Embolism-, and Major Bleeding-Related Health-Care Costs Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Oral Anticoagulants. Clinical and Applied Thrombosis/Hemostasis, 24 (4), 1076029617750269-611. doi: 10.1177/1076029617750269
2018
Journal Article
Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach
Li, Xiaoyan, Keshishian, Allison, Hamilton, Melissa, Horblyuk, Ruslan, Gupta, Kiran, Luo, Xuemei, Mardekian, Jack, Friend, Keith, Nadkarni, Anagha, Pan, Xianying, Lip, Gregory Y. H. and Deitelzweig, Steve (2018). Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach. PLoS One, 13 (1) e0191722, e0191722. doi: 10.1371/journal.pone.0191722
2017
Journal Article
Effect of Apixaban Versus Warfarin Use on Health Care Resource Utilization and Costs Among Elderly Patients with Nonvalvular Atrial Fibrillation
Deitelzweig, Steven, Luo, Xuemei, Gupta, Kiran, Trocio, Jeffrey, Mardekian, Jack, Curtice, Tammy, Lingohr-Smith, Melissa, Menges, Brandy and Lin, Jay (2017). Effect of Apixaban Versus Warfarin Use on Health Care Resource Utilization and Costs Among Elderly Patients with Nonvalvular Atrial Fibrillation. Journal of Managed Care & Specialty Pharmacy, 23 (11), 1191-1201. doi: 10.18553/jmcp.2017.17060
2017
Journal Article
Comparison of effectiveness and safety of treatment with apixaban vs. other oral anticoagulants among elderly nonvalvular atrial fibrillation patients
Deitelzweig, Steven, Luo, Xuemei, Gupta, Kiran, Trocio, Jeffrey, Mardekian, Jack, Curtice, Tammy, Lingohr-Smith, Melissa, Menges, Brandy and Lin, Jay (2017). Comparison of effectiveness and safety of treatment with apixaban vs. other oral anticoagulants among elderly nonvalvular atrial fibrillation patients. Current Medical Research and Opinion, 33 (10), 1745-1754. doi: 10.1080/03007995.2017.1334638
2017
Journal Article
Incremental economic burden associated with major bleeding among atrial fibrillation patients treated with factor Xa inhibitors
Deitelzweig, Steven, Neuman, W. Richey, Lingohr-Smith, Melissa, Menges, Brandy and Lin, Jay (2017). Incremental economic burden associated with major bleeding among atrial fibrillation patients treated with factor Xa inhibitors. Journal of Medical Economics, 20 (12), 1217-1223. doi: 10.1080/13696998.2017.1362412
2017
Journal Article
Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in "real-world" clinical practice: a propensity-matched analysis of 76,940 patients
Li, Xiaoyan, Deitelzweig, Steve, Keshishian, Allison, Hamilton, Melissa, Horblyuk, Ruslan, Gupta, Kiran, Luo, Xuemei, Mardekian, Jack, Friend, Keith, Nadkarni, Anagha, Pan, Xianying and Lip, Gregory Y. H. (2017). Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in "real-world" clinical practice: a propensity-matched analysis of 76,940 patients. Thrombosis and Haemostasis, 117 (6), 1072-1082. doi: 10.1160/TH17-01-0068
2017
Conference Publication
Real World Evaluation of Major Bleeding Risk and Costs for All Causes and Bleeding-Related Health Services Among Elderly Patients with Nonvalvular Atrial Fibrillation Treated with Apixaban or Warfarin
Deitelzweig, Steven, Luo, Xuemei, Gupta, Kiran, Trocio, Jeffrey, Mardekian, Jack, Cutice, Tammy, Lingohr-Smith, Melissa, Menges, Brandy and Lin, Jay (2017). Real World Evaluation of Major Bleeding Risk and Costs for All Causes and Bleeding-Related Health Services Among Elderly Patients with Nonvalvular Atrial Fibrillation Treated with Apixaban or Warfarin. 66th Annual Scientific Session and Expo of the American College of Cardiology (ACC), Washington DC, United States, Mar 17-19, 2017. San Diego, United States: Elsevier.
Supervision
Availability
- Professor Steve Deitelzweig is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Media
Enquiries
For media enquiries about Professor Steve Deitelzweig's areas of expertise, story ideas and help finding experts, contact our Media team: